FDA Approved: * February 9, 2021
Pharm Company: * MYLAN
Category: Laxative

Linaclotide, (sold under the brand name Linzess in the US and Mexico, and as Constella elsewhere)[2] is a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause.[3][4] It has a black box warning about the risk of serious dehydration in children in the US; the most common adverse effects in others are gastrointestinal.[3] It is an oligo-peptide agonist of guanylate cyclase 2C and... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Related Brands

Drugs with the same active ingredients

Popular Topics


is the new drug linzess a probiotic? ## It's actually a peptide agonist that's being evaluated for treat the abd...